PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27320862-5	2016	SNU-368 CD44(+) cells showed EMT through up-regulation of the AKT/GSK-3beta/beta-catenin pathway.	4-(1H-Pyrrol-1-yl)aniline	0-3	AKT serine/threonine kinase 1	Homo sapiens	62-65	
27320862-9	2016	SB431542-treated SNU-368 (CD44/TGF-beta1(-)) cells also showed diminished N-cadherin and AKT/GSK-3beta/beta-catenin pathway activity and further decreased cell motility in a wound healing assay.	4-(1H-Pyrrol-1-yl)aniline	17-20	AKT serine/threonine kinase 1	Homo sapiens	89-92	
34486197-3	2021	In the present study, we found that the expression of HGF, p-Akt, p-ERK, and PD-L1 was increased in cisplatin-treated SNU-368 and SNU-739 cells.	4-(1H-Pyrrol-1-yl)aniline	118-121	AKT serine/threonine kinase 1	Homo sapiens	61-64